NIH starts clinical research consortium

Oct 03, 2006

The U.S. National Institutes of Health is forming a consortium to transform how the nation's clinical and translational research is conducted.

The consortium begins with 12 academic health centers located across the nation. An additional 52 centers will receive planning grants to help them prepare applications to join the group.

When fully implemented in 2012, about 60 institutions will be linked to energize the discipline of clinical and translational science.

"The development of this consortium represents the first systematic change in our approach to clinical research in 50 years," said NIH Director Elias Zerhouni. "Working together, these sites will serve as discovery engines that will improve medical care by applying new scientific advances to real world practice.

The first set of five-year grants will be awarded: Columbia University Health Sciences, Duke University, the Mayo Clinic College of Medicine, the Oregon Health & Science University, Rockefeller University, Yale University, the Texas Health Science Center, and the universities of California-Davis, California-San Francisco, Pennsylvania, Pittsburgh and Rochester.

Copyright 2006 by United Press International

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Fewer lectures, more group work

Dec 18, 2014

Professor Cees van der Vleuten from Maastricht University is a Visiting Professor at Wits University who believes that learning should be student centred.

New research could help the welfare of working animals

Dec 10, 2014

With over 42 million horses and 95 per cent of the world's donkeys found in developing countries, new research could change the health and welfare of millions of working animals in some of the poorest parts ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.